Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications

Northwell Health

Status: Terminated

Conditions: Fetal Aneuploidy; Pregnancy

Study type: Observational

Funder types: Other

Identifiers

NCT01404221

IRB 07-077

Details and patient eligibility

About

Can a combination of prenatal screening blood tests, early ultrasound, and a 3D ultrasound of the fetal face at approximately 20 weeks gestation identify fetuses with congenital anomalies and predict maternal and fetal complications?

Full description

Pts will be consented upon presenting to the department for a comprehensive ultrasound.The 3D picture is the only part of the study that is not part of standard obstetrical care.

Enrollment: 350 patients

Sex: Female

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Pregnant women at approximately 20 weeks
• ages 18-50
• singleton pregnancy
• plans to deliver at North Shore University Hosp
• completed step-wise sequential screening

Exclusion criteria

• multifetal gestation
• minors
• patients who have undergone diagnostic genetic testing
• incarcerated patients
• intention to deliver at a hospital other than North Shore University hosp